Correction: Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients

Detalles Bibliográficos
Autores principales: Wang, Bihua, Zhu, Zhidan, Huang, Feng, Huang, Haowen, Tu, Luxia, Wang, Ying, Zheng, Linfeng, Zhou, Jing, Wei, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513965/
https://www.ncbi.nlm.nih.gov/pubmed/36162983
http://dx.doi.org/10.1186/s12882-022-02950-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513965/
https://www.ncbi.nlm.nih.gov/pubmed/36162983
http://dx.doi.org/10.1186/s12882-022-02950-0

Ejemplares similares